FibroGen, Inc.

FibroGen, Inc. logo
🇺🇸United States
Ownership
Public
Established
1993-01-01
Employees
486
Market Cap
$38.6M
Website
http://www.fibrogen.com

Evaluate the Safety and Efficacy of FG-3019 (Pamrevlumab) in Participants With Idiopathic Pulmonary Fibrosis (IPF)

First Posted Date
2013-07-01
Last Posted Date
2020-09-04
Lead Sponsor
FibroGen
Target Recruit Count
160
Registration Number
NCT01890265
Locations
🇺🇸

Pensacola Research Consultants, Inc., d.b.a. Avanza Medical Research Center, Pensacola, Florida, United States

🇺🇸

Columbia University Medical Center, New York, New York, United States

🇦🇺

Concord Repatriation, Concord, New South Wales, Australia

and more 39 locations

A Study of Roxadustat for the Treatment of Anemia in Participants With Chronic Kidney Disease and Not Receiving Dialysis

Phase 3
Completed
Conditions
Interventions
First Posted Date
2012-12-17
Last Posted Date
2021-10-01
Lead Sponsor
FibroGen
Target Recruit Count
922
Registration Number
NCT01750190
Locations
🇦🇷

Investigational Product, Villa Domínico, Provincia De Buenos Aires, Argentina

🇹🇭

Investigational Site, Chiang Mai, Thailand

🇵🇭

Investigational site, Pasig, Philippines

Open-Label Extension Study for the Long-Term Efficacy and Safety of Roxadustat in Participants With Dialysis and Non-Dialysis Chronic Kidney Disease

First Posted Date
2012-06-28
Last Posted Date
2021-10-01
Lead Sponsor
FibroGen
Target Recruit Count
15
Registration Number
NCT01630889
Locations
🇵🇷

CAIMED School of Medicine, Ponce, Puerto Rico

🇵🇷

Consolidated Medical Plaza, Caguas, Puerto Rico

🇺🇸

Mountain Kidney & HTN Associates, PA, Asheville, North Carolina, United States

and more 2 locations

Study of FG-4592 in Subjects With Chronic Kidney Disease in China

Phase 2
Completed
Conditions
Interventions
First Posted Date
2012-05-16
Last Posted Date
2014-03-03
Lead Sponsor
FibroGen
Target Recruit Count
91
Registration Number
NCT01599507
Locations
🇨🇳

First Affiliated Hospital, Sun Yat-Sen University, Guangzhou, China

🇨🇳

Peking University First Hospital, Beijing, China

🇨🇳

West China Hospital, Chengdu, China

and more 10 locations

Study of FG-4592 in Subjects With End-Stage Renal Disease Receiving Maintenance Hemodialysis in China

First Posted Date
2012-05-11
Last Posted Date
2013-02-04
Lead Sponsor
FibroGen
Target Recruit Count
96
Registration Number
NCT01596855
Locations
🇨🇳

Peking Union Medical College Hospital, Beijing, China

🇨🇳

Chang Zheng Hospital, Shanghai, China

🇨🇳

RuiJin Hospital, Shanghai, China

and more 6 locations

Study of Roxadustat (FG-4592) to Correct Anemia in Newly Initiated Dialysis Participants Not on Erythropoiesis-Stimulating Agent Treatment

Phase 2
Completed
Conditions
Interventions
First Posted Date
2011-08-11
Last Posted Date
2021-10-01
Lead Sponsor
FibroGen
Target Recruit Count
60
Registration Number
NCT01414075

Study to Investigate the Interaction Between FG-4592 and Rosiglitazone in Healthy Adult Subjects

Phase 1
Completed
Conditions
Interventions
First Posted Date
2011-06-20
Last Posted Date
2011-06-20
Lead Sponsor
FibroGen
Target Recruit Count
20
Registration Number
NCT01376063

Safety, Tolerability, and Efficacy Study of Idiopathic Pulmonary Fibrosis

Phase 2
Completed
Conditions
Interventions
First Posted Date
2010-12-17
Last Posted Date
2019-10-09
Lead Sponsor
FibroGen
Target Recruit Count
90
Registration Number
NCT01262001
Locations
🇺🇸

University of Alabama at Birmingham Hospital, Birmingham, Alabama, United States

🇺🇸

Tampa General Hospital, Tampa, Florida, United States

🇺🇸

The Ohio State University, Columbus, Ohio, United States

and more 15 locations

Study of Roxadustat in Non-Dialysis Chronic Kidney Disease Participants With Anemia

Phase 2
Completed
Conditions
Interventions
First Posted Date
2010-11-19
Last Posted Date
2022-02-10
Lead Sponsor
FibroGen
Target Recruit Count
145
Registration Number
NCT01244763

A Study of FG-3019 in Subjects With Liver Fibrosis Due to Chronic Hepatitis B Infection

First Posted Date
2010-10-08
Last Posted Date
2016-08-16
Lead Sponsor
FibroGen
Target Recruit Count
114
Registration Number
NCT01217632
Locations
🇭🇰

Ruttonjee Hospital, Wanchai, Hong Kong Island, Hong Kong

🇹🇭

Siriraj Hospital, Siriaj, Bangkok Noi, Thailand

🇹🇭

Maharaj Nakorn Chiang Mai Hospital, Amphur Muang, Chiang Mai, Thailand

and more 6 locations
© Copyright 2024. All Rights Reserved by MedPath